Literature DB >> 19674194

The role of traumatic event history in non-medical use of prescription drugs among a nationally representative sample of US adolescents.

Jenna L McCauley1, Carla Kmett Danielson, Ananda B Amstadter, Kenneth J Ruggiero, Heidi S Resnick, Rochelle F Hanson, Daniel W Smith, Benjamin E Saunders, Dean G Kilpatrick.   

Abstract

BACKGROUND: Building on previous research with adolescents that examined demographic variables and other forms of substance abuse in relation to non-medical use of prescription drugs (NMUPD), the current study examined potentially traumatic events, depression, posttraumatic stress disorder (PTSD), other substance use, and delinquent behavior as potential correlates of past-year non-medical use of prescription drugs.
METHOD: A nationally representative sample of 3,614 non-institutionalized, civilian, English-speaking adolescents (aged 12-17 years) residing in households with a telephone was selected. Demographic characteristics, traumatic event history, mental health, and substance abuse variables were assessed. NMUPD was assessed by asking if, in the past year, participants had used a prescription drug in a non-medical manner. Multivariable logistic regressions were conducted for each theoretically derived predictor set. Significant predictors from each set were then entered into a final multivariable logistic regression to determine significant predictors of past-year NMUPD.
RESULTS: NMUPD was endorsed by 6.7% of the sample (n = 242). The final multivariable model showed that lifetime history of delinquent behavior, other forms of substance use/abuse, history of witnessed violence, and lifetime history of PTSD were significantly associated with increased likelihood of NMUPD.
CONCLUSIONS: Risk reduction efforts targeting NMUPD among adolescents who have witnessed significant violence, endorsed abuse of other substances and delinquent behavior, and/or endorsed PTSD are warranted. Interventions for adolescents with history of violence exposure or PTSD, or those adjudicated for delinquent behavior, should include treatment or prevention modules that specifically address NMUPD.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19674194      PMCID: PMC2826795          DOI: 10.1111/j.1469-7610.2009.02134.x

Source DB:  PubMed          Journal:  J Child Psychol Psychiatry        ISSN: 0021-9630            Impact factor:   8.982


  26 in total

1.  Medical and nonmedical stimulant use among adolescents: from sanctioned to unsanctioned use.

Authors:  C Poulin
Journal:  CMAJ       Date:  2001-10-16       Impact factor: 8.262

Review 2.  College on Problems of Drug Dependence taskforce on prescription opioid non-medical use and abuse: position statement.

Authors:  James Zacny; George Bigelow; Peggy Compton; Kathleen Foley; Martin Iguchi; Christine Sannerud
Journal:  Drug Alcohol Depend       Date:  2003-04-01       Impact factor: 4.492

Review 3.  Addiction motivation reformulated: an affective processing model of negative reinforcement.

Authors:  Timothy B Baker; Megan E Piper; Danielle E McCarthy; Matthew R Majeskie; Michael C Fiore
Journal:  Psychol Rev       Date:  2004-01       Impact factor: 8.934

4.  Risk factors for adolescent substance abuse and dependence: data from a national sample.

Authors:  D G Kilpatrick; R Acierno; B Saunders; H S Resnick; C L Best; P P Schnurr
Journal:  J Consult Clin Psychol       Date:  2000-02

5.  The use, misuse and diversion of prescription stimulants among middle and high school students.

Authors:  Sean Esteban McCabe; Christian J Teter; Carol J Boyd
Journal:  Subst Use Misuse       Date:  2004-06       Impact factor: 2.164

6.  Prescription pain reliever abuse and dependence among adolescents: a nationally representative study.

Authors:  Li-Tzy Wu; Christopher L Ringwalt; Paolo Mannelli; Ashwin A Patkar
Journal:  J Am Acad Child Adolesc Psychiatry       Date:  2008-09       Impact factor: 8.829

7.  Mental health service and medication use in New York City after the September 11, 2001, terrorist attack.

Authors:  Joseph A Boscarino; Sandro Galea; Richard E Adams; Jennifer Ahern; Heidi Resnick; David Vlahov
Journal:  Psychiatr Serv       Date:  2004-03       Impact factor: 3.084

8.  Is disclosure of childhood rape associated with mental health outcome? Results from the National Women's Study.

Authors:  Kenneth J Ruggiero; Daniel W Smith; Rochelle F Hanson; Heidi S Resnick; Benjamin E Saunders; Dean G Kilpatrick; Connie L Best
Journal:  Child Maltreat       Date:  2004-02

9.  Correlates of adolescent reports of sexual assault: findings from the National Survey of Adolescents.

Authors:  Rochelle F Hanson; Lisha W Kievit; Benjamin E Saunders; Daniel W Smith; Dean G Kilpatrick; Heidi S Resnick; Kenneth J Ruggiero
Journal:  Child Maltreat       Date:  2003-11

10.  Violence and risk of PTSD, major depression, substance abuse/dependence, and comorbidity: results from the National Survey of Adolescents.

Authors:  Dean G Kilpatrick; Kenneth J Ruggiero; Ron Acierno; Benjamin E Saunders; Heidi S Resnick; Connie L Best
Journal:  J Consult Clin Psychol       Date:  2003-08
View more
  33 in total

1.  Understanding the rural-urban differences in nonmedical prescription opioid use and abuse in the United States.

Authors:  Katherine M Keyes; Magdalena Cerdá; Joanne E Brady; Jennifer R Havens; Sandro Galea
Journal:  Am J Public Health       Date:  2013-12-12       Impact factor: 9.308

2.  Transition from first illicit drug use to first injection drug use among rural Appalachian drug users: a cross-sectional comparison and retrospective survival analysis.

Authors:  April M Young; Jennifer R Havens
Journal:  Addiction       Date:  2011-10-26       Impact factor: 6.526

3.  A prospective examination of the relationships between PTSD, exposure to assaultive violence, and cigarette smoking among a national sample of adolescents.

Authors:  Josh M Cisler; Ananda B Amstadter; Angela M Begle; Heidi S Resnick; Carla Kmett Danielson; Ben E Saunders; Dean G Kilpatrick
Journal:  Addict Behav       Date:  2011-06-12       Impact factor: 3.913

4.  The relationships of childhood trauma and adulthood prescription pain reliever misuse and injection drug use.

Authors:  Kelly Quinn; Lauren Boone; Joy D Scheidell; Pedro Mateu-Gelabert; Susan P McGorray; Nisha Beharie; Linda B Cottler; Maria R Khan
Journal:  Drug Alcohol Depend       Date:  2016-10-04       Impact factor: 4.492

5.  Predicting adolescents' persistence, non-persistence, and recent onset of nonmedical use of opioids and stimulants.

Authors:  Brandon Nakawaki; William D Crano
Journal:  Addict Behav       Date:  2012-02-17       Impact factor: 3.913

6.  High levels of self-reported prescription opioid use by HIV-positive individuals.

Authors:  Abigail Norris Turner; Courtney Maierhofer; Nicholas T Funderburg; Brandon Snyder; Kristi Small; Jan Clark; Jose A Bazan; Nicole C Kwiek; Jesse J Kwiek
Journal:  AIDS Care       Date:  2016-06-20

7.  Internalizing and externalizing factors on the pathway from adverse experiences in childhood to non-medical prescription opioid use in adulthood.

Authors:  Kelly Quinn; Bartley C Frueh; Joy Scheidell; Daniel Schatz; Faith Scanlon; Maria R Khan
Journal:  Drug Alcohol Depend       Date:  2019-02-14       Impact factor: 4.492

8.  Coping and emotion regulation profiles as predictors of nonmedical prescription drug and illicit drug use among high-risk young adults.

Authors:  Carolyn F Wong; Karol Silva; Aleksandar Kecojevic; Sheree M Schrager; Jennifer Jackson Bloom; Ellen Iverson; Stephen E Lankenau
Journal:  Drug Alcohol Depend       Date:  2013-02-28       Impact factor: 4.492

9.  Co-occurring prescription opioid use problems and posttraumatic stress disorder symptom severity.

Authors:  Andrea Meier; Chantal Lambert-Harris; Mark P McGovern; Haiyi Xie; Melissa An; Bethany McLeman
Journal:  Am J Drug Alcohol Abuse       Date:  2014-05-08       Impact factor: 3.829

10.  Nonmedical use of prescription opioids among adolescents: subtypes based on motivation for use.

Authors:  Amy Young; Sean Esteban McCabe; James A Cranford; Paula Ross-Durow; Carol J Boyd
Journal:  J Addict Dis       Date:  2012
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.